...Sept 2011 for $325M in cash plus up to $150M in milestones Azelon Pharmaceuticals Inc./ Zelos Therapeutics Inc....

...San Diego, Calif. Business: Pulmonary Hired: Jaisim Shah as SVP and CBO, formerly president of Zelos Therapeutics Inc....

...Business: Musculoskeletal Hired: David Krause as CMO, formerly CMO, SVP and head of R&D at Zelos Therapeutics Inc. WIR...

...serotonin you can induce bone formation" with an oral therapeutic, said Brian MacDonald, CEO of Zelos Therapeutics Inc....
...anabolic response with a non-PTH therapeutic, you could conceivably capture the whole market," said MacDonald. Zelos'...
...Pharmaceuticals Inc. (NASDAQ:NPSP), Bedminster, N.J. Nycomed , Zurich, Switzerland Symphony Icon Inc. , Rockville, Md. Zelos Therapeutics Inc....

...formulation of ZT-034 vs. injectable Forteo teriparatide for 7 days in 50 healthy postmenopausal women. Zelos...
...testing (see BioCentury, Oct. 12, 2009). Eli Lilly and Co. (NYSE:LLY, Indianapolis, Ind.) markets Forteo. Zelos Therapeutics Inc....

...signaling without a similar upregulation of OSM-OSMR signaling. Brian MacDonald, CEO of bone disorder company Zelos Therapeutics Inc....
...Brussels, Belgium The Walter and Eliza Hall Institute of Medical Research , Parkville, Victoria, Australia Zelos Therapeutics Inc....

...vs. Forteo teriparatide from Eli Lilly and Co. (NYSE:LLY, Indianapolis, Ind.) in 16 healthy volunteers. Zelos Therapeutics Inc....

...NYSE:MRK, Whitehouse Station, N.J.). The company has not disclosed a start timeframe for the study. Zelos Therapeutics Inc....

...technology to develop an intranasal version of ZT-031 to treat osteoporosis and other bone diseases. Zelos'...
...to treat osteoporosis. Financial terms were not disclosed. Aegis Therapeutics LLC , San Diego, Calif. Zelos Therapeutics Inc....